Work

Cancer immunotherapy targeting survivin: commentary re: V. Pisarev et al., full-length dominant-negative survivin for cancer immunotherapy. Clin. Cancer Res., 9:6523-6533, 2003.

Year: 2003

Type: article

Source: PubMed

Authors: John C Reed, Darcy B Wilson

Institution: Sanford Burnham Prebys Medical Discovery Institute

Language: English

Topic: Immunotherapy and Immune Responses

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Institute on Aging, National Cancer Institute

Awards: Inhibition of Proteases by IAPs, COMBINATORIAL APPROACHES TO TREAT NEOPLASTIC DISEASES

OpenAlex ID: W2144625209

FWCI: 0.727

Cites: 25

Cited by: 22

Related to: 10